source
- The R&D 15: How pharma's top companies spent, won and lost on drug researchTalking over pharma pipelines with a major drugmaker's development chief, he noted that if you looked at the biggest 50 drugs by revenue, the final one on the list brought in about $4 billion last ...Endpoints · 3mo ago↗ source
- Novartis unveils North Carolina factory as final new build in $23B US expansionNovartis on Thursday revealed its plans to build another factory in the US, with the Swiss drugmaker noting that it has now allocated every dollar of its $23 billion promise to expand ...Endpoints · 3mo ago↗ source
- Avalyn, in pursuit of better lung drugs, banks $300M in an IPOThe biotech will use the proceeds to develop inhalable versions of therapies already on the market for the “idiopathic” and “progressive” forms of pulmonary fibrosis.